The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
Enthral.ai’s platform integrates AI-driven capabilities with compliance-first architecture, enabling automated training workflows
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
The open-label trial involved 105 adults with schizophrenia who were on a stable dose of an oral atypical antipsychotic for at least six weeks
Allergan also presented new insights on the growing population of patients on GLP-1 agonists for weight loss who are seeking aesthetic treatments
The SCOUT-HCM trial hit its primary endpoint, showing a clinically meaningful and statistically significant reduction in Valsalva left ventricular outflow tract
Subscribe To Our Newsletter & Stay Updated
